Skip to content

Observational Study of Risk Factors for Peripheral Artery Disease in Bathroom Scale Withings Body Cardio Users

Observational Study of Risk Factors for Peripheral Artery Disease in Bathroom Scale Withings Body Cardio Users

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07082517
Acronym
OBAOMI
Enrollment
1000
Registered
2025-07-24
Start date
2021-06-03
Completion date
2022-03-16
Last updated
2025-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PAD - Peripheral Arterial Disease

Brief summary

Withings Body Cardio is capable to measure PWV in the right and left lower limbs. The hypothesis of this study is a significant difference in PWV between the right and left lower limbs measured by the device may be the sign of people with more risk factors that may lead to a PAD.

Detailed description

Active users of WITHINGS Body Cardio bathroom scale will be invited to participate to the study. In case of a positive answer, the user will receive an electronic questionnaire about its health and medical history and the data recorded from the previous six months on his/her Body Cardio bathroom scale will be collected in the study. Once consent has been given, the user's data collectedby the WITHINGS Body Cardio scales will be extracted anonymously and associated with the answers to the questionnaire.

Interventions

OTHERPercentage analysis

Analysis the percentage of the population with risk factors that may lead to a PAD.

Sponsors

Withings
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Active and regular user of the device * Adult participant * Participant who agreed to participate in the study, after reading the study information letter * Participant living in France

Exclusion criteria

* User who didn't agreed to participate to the study after reading the study information letter

Design outcomes

Primary

MeasureTime frameDescription
Analysis of the distribution of risk factors for people with a high People with significant PWV difference will be compared to people with no significant PWV difference1 yearChi 2 test between the two population

Secondary

MeasureTime frameDescription
Acceptability of the device1 yearAmount of daily use of the device

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026